Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
FEMY
FEMY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FEMY News
Femasys Partners with OR Consulting for Swiss Market Launch
Feb 03 2026
Newsfilter
Atossa Therapeutics Receives FDA Orphan Drug Designation, Stock Rises Nearly 13%
Jan 20 2026
NASDAQ.COM
Femasys (FEMY) Receives Nasdaq Approval for 180-Day Compliance Extension Until July 2026
Jan 14 2026
seekingalpha
Alumis Inc. (ALMS) Shares Surge 17.33% on Phase 3 Clinical Trial Data Announcement
Jan 06 2026
NASDAQ.COM
Multi Ways Holdings Reports 87.65% Revenue Growth to $26.44 Million in H1 2025
Dec 24 2025
Benzinga
Weekly Update: CYTK Receives Initial FDA Approval, INSM Concludes Rhinosinusitis Research, XOMA Purchases GBIO
Dec 20 2025
NASDAQ.COM
Femasys Receives FDA Clearance for FemVue Controlled Device
Dec 18 2025
Newsfilter
Femasys Receives FDA Clearance for FemVue Controlled Device
Dec 18 2025
Globenewswire
Femasys Obtains FDA Approval for Advanced FemVue Diagnostic Device
Dec 18 2025
Yahoo Finance
PharmaCyte Monetizes Femasys Stake, Boosts Cash to $20 Million
Nov 25 2025
Newsfilter
INBX Rises 81% Following Study Results; FEMY, CING, CYH Surge in After-Hours Trading
Oct 24 2025
NASDAQ.COM
VTI ETF Update, October 3, 2025
Oct 03 2025
TipRanks
Femasys Collaborates with Medical Electronic Systems on FemSperm Kit Development
Sep 23 2025
Yahoo Finance
Femasys Collaborates with Medical Electronic Systems to Introduce FemSperm™ Analysis Kit for FemaSeed Use
Sep 22 2025
Newsfilter
Femasys Sets $8 Million Public Offering to Support Product Development and Business Growth
Aug 27 2025
NASDAQ.COM
Crude Oil Prices Fall 2%; US Durable Goods Orders Decrease in July
Aug 26 2025
Benzinga
Show More News
